In our Evi1 knock-out studies of CML-CP and BC mice, Evi1 heterozygosity alleviated the disease (Figures 3g and 5e), highlighting a functional role of Evi1 in CML pathogenesis. This evidence concerns the gene MECOM and chronic myelogenous leukemia, BCR-ABL1 positive.